Meag Munich Ergo’s Nektar Therapeutics NKTR Stock Holding History

Meag Munich Ergo’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-706	Closed	-$189K	–	526
2019 Q3	$189K	Buy	706 +225	+47%	+$82.5K	0.01%	517
2019 Q2	$250K	Hold	481	–	–	0.02%	496
2019 Q1	$236K	Buy	+481	New	+$285K	0.02%	503

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Meag Munich Ergo's NKTR Position: Q4 2019 in Review

Meag Munich Ergo sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 706 shares — an estimated $189K sold.

Meag Munich Ergo first reported a position in NKTR in Q1 2019 and held it in 3 quarters. The position peaked at $250K in Q2 2019. 281 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

Meag Munich Ergo reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
Meag Munich Ergo sold 706 Nektar Therapeutics shares in Q4 2019, an estimated $189K.
Meag Munich Ergo first reported a position in Nektar Therapeutics in Q1 2019 and held it in 3 quarters.
Meag Munich Ergo's Nektar Therapeutics position peaked at $250K in Q2 2019.
281 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Meag Munich Ergo's 13F filing for Q4 2019, filed 17 Jan 2020.